University of Pennsylvania Health System

Penn Health and Wellness

We'd like to know what types of information you find most valuable or relevant. Please take this brief survey.

Thursday, September 1, 2011

Ovarian Cancer Awareness Month – New Treatment Advances at Penn

September is Ovarian Cancer Awareness Month. Ovarian cancer affects 1 in 57 women in the United States and two thirds of those diagnosed are age 55 or older.

The fifth leading cause of cancer-related deaths in women with no distinct symptoms in its early stages, ovarian cancer is often diagnosed after the disease is advanced. The symptoms often associated with ovarian cancer include abdominal or pelvic pain, bloating, difficulty eating, feeling full quickly and urinary urgency or frequency.

Penn Medicine is making prevention, early detection and treatment of ovarian cancer a priority. Penn researchers are working every day to create new therapies and increase the chances for a cure.

Led by George Coukos, MD, PhD, the Penn Ovarian Cancer Research Center (OCRC) is developing new approaches to treating ovarian cancer that improve survival rates and enable women affected by this disease to live a better quality of life. The OCRC utilizes personalized immunotherapy, which is an innovative treatment approach using the patient’s own tumor to derive cancer vaccines and cell–based therapeutics. The OCRC is currently enrolling patients in three phase I/II clinical trials for patients with recurrent ovarian, fallopian tube or primary peritoneal cancer.

Get Information about Gynecologic Oncology Services at Penn Medicine
Learn More about Personalized Immunotherapy
Read about Clinical Trials at Penn Medicine

Remove Unwanted Varicose Veins with the New VNUS Closure Procedure

Approximately 25 million Americans suffer from venous disease, a condition that causes varicose veins and other painful symptoms. Penn Medicine is pleased to offer the new VNUS Closure® procedure, a minimally invasive alternative for patients with superficial venous reflux, which is an underlying cause of varicose veins.

In the VNUS Closure procedure, physicians close diseased veins and re-route blood to healthier veins. It provides relief from painful symptoms and results in less bruising than traditional vein stripping surgery and laser treatment. Patients typically can return to normal activities within a day or two after the outpatient procedure, which is covered by most health insurance providers. Please speak with a health care provider to learn more and discuss eligibility.

Attend a vein screening at Penn Medicine to see if you are a candidate for the VNUS Closure® procedure
Learn More about Varicose Veins
Related Posts with Thumbnails